Literature DB >> 11824560

Metabolism of kalopanaxsaponin K by human intestinal bacteria and antirheumatoid arthritis activity of their metabolites.

Dong-Hyun Kim1, Eun-Ah Bae, Myung Joo Han, Hee-Juhn Park, Jong-Won Choi.   

Abstract

When kalopanaxsaponin K (KPK) from Kalopanax pictus was incubated for 24 h at 37 degrees C with human intestinal microflora, KPK was mainly metabolized to kalopanaxsaponin I (KPI) via kalopanaxsaponin H (KPH) rather than via kalopanaxsaponin J (KPJ), and then transformed to kalopanaxsaponin A (KPA) and hederagenin. Bacteroides sp., and Bifidobacterium sp. and Fusobacterium sp. transformed KPK to KPI and KPA and hederagenin via KPH or KPJ. However, Lactobacillus sp. and Streptococcus sp. transformed KPK to KPI, KPA, and hederagenin only via KPJ. The metabolite KPA of KPK showed potent antirheumatoid arthritis activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11824560     DOI: 10.1248/bpb.25.68

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

1.  The Stem Bark of Kalopanax pictus Exhibits Anti-inflammatory Effect through Heme Oxygenase-1 Induction and NF-κB Suppression.

Authors:  Soo Young Bang; Ga-Young Park; Sun Young Park; Ji-Hee Kim; Yun Kyoung Lee; Sang-Joon Lee; Younghee Kim
Journal:  Immune Netw       Date:  2010-12-31       Impact factor: 6.303

2.  Anticandidal Activity of Kalopanaxsaponin A: Effect on Proliferation, Cell Morphology, and Key Virulence Attributes of Candida albicans.

Authors:  Ying Li; Mingzhu Shan; Mingju Yan; Huankai Yao; Yuechen Wang; Bing Gu; Zuobin Zhu; Hongchun Li
Journal:  Front Microbiol       Date:  2019-12-03       Impact factor: 5.640

Review 3.  Current knowledge and development of hederagenin as a promising medicinal agent: a comprehensive review.

Authors:  Jia Zeng; Ting Huang; Man Xue; Jianxing Chen; Linglin Feng; Ruofei Du; Yi Feng
Journal:  RSC Adv       Date:  2018-07-03       Impact factor: 4.036

4.  Kalopanaxsaponin A Exerts Anti-Inflammatory Effects in Lipopolysaccharide-Stimulated Microglia via Inhibition of JNK and NF-κB/AP-1 Pathways.

Authors:  Yeon-Hui Jeong; Jin-Won Hyun; Tien Kim Van Le; Dong-Hyun Kim; Hee-Sun Kim
Journal:  Biomol Ther (Seoul)       Date:  2013-09-30       Impact factor: 4.634

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.